Prolonged exposure to low-dose radiation may increase the risk of hypertension, a known cause of heart disease and stroke

 

DALLAS, USA (May 3, 2019) – Prolonged exposure to low doses of ionizing radiation increased the risk of hypertension, according to a study of workers at a nuclear plant in Russia published in the American Heart Association’s journal Hypertension. Uncontrolled hypertension, also known as high blood pressure, can to lead to heart attack, stroke, heart failure and other serious health problems.

Earlier studies linked exposure to high doses of radiation to increased risk of cardiovascular diseases and death from those diseases. This study is the first to find an increased risk of hypertension to low doses of ionizing radiation among a large group of workers who were chronically exposed over many years.

The study included more than 22,000 workers at the first large-scale nuclear enterprise in Russia known as the Mayak Production Association. The workers were hired between 1948 and 1982, with an average length of time on the job of 18 years. Half had worked there for more than 10 years. All of the workers had comprehensive health check-ups and screening tests at least once a year with advanced evaluations every five years.

The researchers evaluated the workers‘ health records up to 2013. More than 8,400 workers (38 percent of the group) were diagnosed with hypertension, as defined in this study as a systolic blood pressure reading of ?140 mm Hg, and a diastolic reading ? 90 mm Hg. Hypertension incidence was found to be significantly associated with the cumulative dose.

To put it in perspective, the hypertension incidence among the workers in the study was higher than that among Japanese survivors of the atomic bomb at the end of World War II, but lower than the risk estimated for clean-up workers following the Chernobyl nuclear accident.

The differences may be explained by variations in exposure among the three groups, according to the researchers. Following the atomic bombing, the Japanese experienced a single, high-dose exposure of radiation, the Chernobyl workers were exposed to radiation for a short time period (days and months), while the Mayak workers were chronically exposed to low doses of radiation over many years.

While the development of cancer is commonly associated with radiation exposure, „we believe that an estimate of the detrimental health consequences of radiation exposure should also include non-cancer health outcomes. We now have evidence suggesting that radiation exposure may also lead to increased risks of hypertension, cardiovascular disease and cerebrovascular disease, as well,“ said Tamara Azizova, M.D., lead author of the study at the Southern Urals Biophysics Institute in Russia.

Azizova pointed out that in recent years, the number of people exposed to radiation in everyday life, such as during diagnostic procedures, has increased. „It is necessary to inform the public that not only high doses of radiation, but low to moderate doses also increase the risk of hypertension and other circulatory system diseases, which today contribute significantly to death and disability. As a result, all radiological protection principles and dose limits should be strictly followed for workers and the general public.“

How radiation exposure may increase the risk of hypertension is still a question, according to Azizova. „So far, the mechanisms remain unclear, not only for certain cohorts but also for the general population. One of the main tasks for the coming decade is to study the mechanisms of hypertension and heart and brain atherosclerosis occurring in people who are – and who were exposed – to radiation.“

The authors note that their study is a retrospective one, and while many health conditions and behaviors were documented in the medical records of the workers (such as age, smoking, alcohol consumption and body mass index), other factors, such as stress and nutrition, were unavailable for researchers to be taken into account in this study.

 

Co-authors are Ksenia Briks, M.D.; Maria Bannikova, M.Sc.; and Evgeniya Grigorieva, M.Sc. Author disclosures are on the manuscript.

The study was conducted by the Southern Urals Biophysics Institute at the Federal Medical Biological Agency of Russia, as part of continuing research on the effects of radiation exposure on human health.

 

Additional Resources

Available multimedia located on the right column of the release link:

https://newsroom.heart.org/news/prolonged-exposure-to-low-dose-radiation-may-increase-the-risk-of-hypertension-a-known-cause-of-heart-disease-and-stroke?preview=c974f86a466cc46d7a04c4ab7a0a399b

After May 3, 2019, view the manuscript and editorial online.

Follow AHA/ASA news on Twitter @HeartNews

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

 

About the American Heart Association

The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

 


American Heart Association, 03.05.2019 (tB)

Schlagwörter: , ,

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…